DRUG:AU:AU-BetaShares Global Healthcare Currency Hedged (AUD)

ETF | Others |

Last Closing

USD 8.38

Change

+0.07 (+0.84)%

Market Cap

USD 0.17B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.62% 90% A- 68% D+
Dividend Return 0.35% 11% F 9% A-
Total Return 6.96% 91% A- 69% C-
Trailing 12 Months  
Capital Gain -1.99% 7% C- 47% F
Dividend Return 2.93% 41% F 33% F
Total Return 0.94% 9% A- 47% F
Trailing 5 Years  
Capital Gain 23.96% 70% C- 72% C
Dividend Return 10.83% 26% F 27% F
Total Return 34.79% 60% D- 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 6.78% 64% D 55% F
Dividend Return 8.53% 63% D 53% F
Total Return 1.75% 57% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 8.50% 65% D 92% A
Risk Adjusted Return 100.32% 89% A- 96% N/A
Market Capitalization 0.17B 33% F 65% D

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.